Technology
Health
Biotechnology

Stellar Biotechnologies

$1.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.88%) Today
-$0.02 (-1.79%) After Hours

Why Robinhood?

You can buy or sell SBOT and other stocks, options, ETFs, and crypto commission-free!

About

Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. Read More The Company was founded on June 12, 2007 and is headquartered in Port Hueneme, CA.

Employees
25
Headquarters
Port Hueneme, California
Founded
2007
Market Cap
6.02M
Price-Earnings Ratio
Dividend Yield
Average Volume
542.53K
High Today
$1.13
Low Today
$1.08
Open Price
$1.13
Volume
59.89K
52 Week High
$7.63
52 Week Low
$0.75

Collections

Technology
Health
Biotechnology
2015 IPO
US
North America

News

PR NewswireMar 8

Stellar Biotechnologies and Edesa Biotech Sign Share Exchange Agreement

LOS ANGELES, March 8, 2019 /PRNewswire/ -- Stellar Biotechnologies, Inc. (Nasdaq: SBOT), a leading manufacturer of a key protein utilized in immunotherapy and immuno-oncology development pipelines, has executed a share exchange agreement with privately-held Edesa Biotech Inc., a Canadian company, and Edesa's shareholders to create a company focused on the development of innovative therapeutics for dermatological and gastrointestinal indications with clear unmet medical needs. Under the terms of the share e...

586
Simply Wall StFeb 23

Is Stellar Biotechnologies, Inc. (NASDAQ:SBOT) A Volatile Stock?

Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! Anyone researching Stellar Biotechnologies, Inc. (NASDAQ:SBOT) might want to consider the historical volatility of the share price. Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. The first category is company specific volatility. This can be dealt with by limiting your exposure to any particular stock. The second sort is caus...

269
MarketBeatFeb 21

Stock Price, News, & Analysis for Stellar Biotechnologies

Stellar Biotechnologies, Inc., a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein in Europe, North America, and Asia. The company offers KLH, an immune-stimulating protein used in the production of various immunotherapies; and as a carrier molecule or finished injectable product in the immunodiagnostic market. It provides its KLH protein under the Stellar KLH brand. The company's products include Stella...

74

Earnings

-$0.90
-$0.54
-$0.19
$0.17
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected May 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.